Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000725536 | SCV000337591 | uncertain significance | not provided | 2015-11-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000725536 | SCV000534399 | uncertain significance | not provided | 2016-11-22 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the LMNA gene. The L104R variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The L104R variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Additionally, the L104R variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Nevertheless, this L104R variant lacks sufficient evidence, such as segregation studies and functional studies to support its pathogenicity. |